John H. Pemberton
John H. Pemberton has a total of 677 co-authors. Here are the top co-authors by number of shared publications:
B. G. Wolff
Division of Colon and Rectal Surgery, Mayo Clinic, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
4 shared publicationsR. R. Dozois
Division of Colon and Rectal Surgery, Mayo Clinic, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
4 shared publicationsA. Ferrara
Orlando FL
3 shared publicationsA. M. Vernava
St. Louis Mo
3 shared publicationsD. A. Rothenberger
Minneapolis MN
3 shared publicationsD. C. C. Bartolo
Edinburgh Scotland
3 shared publications
Latest Publications
- 22 May 2017
- Published by Georg Thieme Verlag KG in Clinics in Colon and Rectal Surgery
- Vol. 30 (03) , 178-183
The Role of Temporary Fecal Diversion
The use of temporary fecal diversion is of great importance to tenuous anastomosis, immunosuppressed patient, or actively infected patient. Its use protects newly constructed intestinal anastomoses from being the culprit of pelvic sepsis or systemic illness. Thus, potential morbidity and mortality can be averted. However, its appropriate or optimal use is often debated. We herein discuss the evidence for when to best use a diverting stoma for colorectal, coloanal, and ileoanal anastomoses. We also discuss the importance of considering a temporary diverting stoma in the setting of high-dose immunosuppression (e.g., transplant patients or inflammatory bowel disease), active infection, or upon creation of ileal pouch–anal anastomosis. Lastly, we discuss the advantages and disadvantages of a loop ileostomy versus colostomy for temporary diversion of fecal contents.
- 22 May 2017
- Published by Georg Thieme Verlag KG in Clinics in Colon and Rectal Surgery
- Vol. 30 (03) , 178-183
The Role of Temporary Fecal Diversion
The use of temporary fecal diversion is of great importance to tenuous anastomosis, immunosuppressed patient, or actively infected patient. Its use protects newly constructed intestinal anastomoses from being the culprit of pelvic sepsis or systemic illness. Thus, potential morbidity and mortality can be averted. However, its appropriate or optimal use is often debated. We herein discuss the evidence for when to best use a diverting stoma for colorectal, coloanal, and ileoanal anastomoses. We also discuss the importance of considering a temporary diverting stoma in the setting of high-dose immunosuppression (e.g., transplant patients or inflammatory bowel disease), active infection, or upon creation of ileal pouch–anal anastomosis. Lastly, we discuss the advantages and disadvantages of a loop ileostomy versus colostomy for temporary diversion of fecal contents.
- Open Access
- 27 April 2012
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 99 (6) , 879
Authors' reply: Outcomes following surgery without radiotherapy for rectal cancer (Br J Surg 2012; 99: 137–143)
- 27 April 2012
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 99 (6) , 879
Open AccessAuthors' reply: Outcomes following surgery without radiotherapy for rectal cancer (Br J Surg 2012; 99: 137–143)
- 2 November 2011
- Published by Springer Nature
- p. 549-564
Surgical Management of Crohn’s Disease and Ulcerative Colitis
- 2 November 2011
- Published by Springer Nature
- p. 549-564
Surgical Management of Crohn’s Disease and Ulcerative Colitis
- 1 July 2011
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 15 (11) , 2016-2022
Bleeding and Thromboembolic Outcomes for Patients on Oral Anticoagulation Undergoing Elective Colon and Rectal Abdominal Operations
- 1 July 2011
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 15 (11) , 2016-2022
Bleeding and Thromboembolic Outcomes for Patients on Oral Anticoagulation Undergoing Elective Colon and Rectal Abdominal Operations
- 28 February 2010
- Published by Elsevier in Journal of Surgical Research
- Vol. 158 (2) , 271-272
Hand Assisted Laparoscopic Surgery for Colorectal Cancer: Short-Term Outcomes in Over 300 Patients
- 28 February 2010
- Published by Elsevier in Journal of Surgical Research
- Vol. 158 (2) , 271-272
Hand Assisted Laparoscopic Surgery for Colorectal Cancer: Short-Term Outcomes in Over 300 Patients
- 30 September 2009
- Published by Elsevier in Advances in Surgery
- Vol. 43 (1) , 211-219
Can Unresectable Colorectal Cancer Be Cured?
- 30 September 2009
- Published by Elsevier in Advances in Surgery
- Vol. 43 (1) , 211-219
Can Unresectable Colorectal Cancer Be Cured?
- 28 February 2009
- Published by Elsevier in Journal of Surgical Research
- Vol. 151 (2) , 241-242
149. Surgery Resident Work-Hour Restrictions: Impact on Patient Care, Surgical Education and Resident Quality of Life
- 28 February 2009
- Published by Elsevier in Journal of Surgical Research
- Vol. 151 (2) , 241-242
149. Surgery Resident Work-Hour Restrictions: Impact on Patient Care, Surgical Education and Resident Quality of Life
- Open Access
- 21 January 2009
- Published by H1 Connect in F1000 Medicine Reports
- Vol. 1 (10)
Does infliximab increase complications after surgery for inflammatory bowel disease?
Does infliximab increase complications after surgery for inflammatory bowel disease?
- 21 January 2009
- Published by H1 Connect in F1000 Medicine Reports
- Vol. 1 (10)
Open AccessDoes infliximab increase complications after surgery for inflammatory bowel disease?
Does infliximab increase complications after surgery for inflammatory bowel disease?
- 14 December 2007
- Published by Wiley in Journal of Surgical Oncology
- Vol. 96 (8) , 643
Overview for the journal of surgical oncology
- 14 December 2007
- Published by Wiley in Journal of Surgical Oncology
- Vol. 96 (8) , 643
Overview for the journal of surgical oncology
- Top Cited Papers
- 15 January 2007
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 94 (3) , 333-340
Results at up to 20 years after ileal pouch–anal anastomosis for chronic ulcerative colitis
Background: Ileal pouch–anal anastomosis (IPAA) is performed routinely for chronic ulcerative colitis. Methods: Using data from a prospective database and annual standardized questionnaires, functional outcome, complications and quality of life (QoL) after IPAA were assessed. Results: Some 1885 IPAA operations were performed for chronic ulcerative colitis over a 20‐year period (mean follow‐up 11 years). The mean age at the time of IPAA was 34·1 years, increasing from 31·2 years (1981–1985) to 36·3 years (1996–2000). The overall rate of pouch success at 5, 10, 15 and 20 years was 96·3, 93·3, 92·4 and 92·1 per cent respectively. Mean daytime stool frequency increased from 5·7 at 1 year to 6·4 at 20 years (P < 0·001), and also increased at night (from 1·5 to 2·0; P < 0·001). The incidence of frequent daytime faecal incontinence increased from 5 to 11 per cent during the day (P < 0·001) and from 12 to 21 per cent at night (P < 0·001). QoL remained unchanged and 92 per cent remained in the same employment. Seventy‐six patients were eventually diagnosed with indeterminate colitis and 47 with Crohn's disease. Conclusion: IPAA is a reliable surgical procedure for patients requiring proctocolectomy for chronic ulcerative colitis and indeterminate colitis. The clinical and functional outcomes are excellent and stable for 20 years after operation. Copyright © 2006 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.
- 15 January 2007
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 94 (3) , 333-340
Top Cited PapersResults at up to 20 years after ileal pouch–anal anastomosis for chronic ulcerative colitis
Background: Ileal pouch–anal anastomosis (IPAA) is performed routinely for chronic ulcerative colitis. Methods: Using data from a prospective database and annual standardized questionnaires, functional outcome, complications and quality of life (QoL) after IPAA were assessed. Results: Some 1885 IPAA operations were performed for chronic ulcerative colitis over a 20‐year period (mean follow‐up 11 years). The mean age at the time of IPAA was 34·1 years, increasing from 31·2 years (1981–1985) to 36·3 years (1996–2000). The overall rate of pouch success at 5, 10, 15 and 20 years was 96·3, 93·3, 92·4 and 92·1 per cent respectively. Mean daytime stool frequency increased from 5·7 at 1 year to 6·4 at 20 years (P < 0·001), and also increased at night (from 1·5 to 2·0; P < 0·001). The incidence of frequent daytime faecal incontinence increased from 5 to 11 per cent during the day (P < 0·001) and from 12 to 21 per cent at night (P < 0·001). QoL remained unchanged and 92 per cent remained in the same employment. Seventy‐six patients were eventually diagnosed with indeterminate colitis and 47 with Crohn's disease. Conclusion: IPAA is a reliable surgical procedure for patients requiring proctocolectomy for chronic ulcerative colitis and indeterminate colitis. The clinical and functional outcomes are excellent and stable for 20 years after operation. Copyright © 2006 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.